rs1801574

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000350.3(ABCA4):​c.5682G>C​(p.Leu1894Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 1,613,792 control chromosomes in the GnomAD database, including 46,504 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L1894L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.23 ( 4307 hom., cov: 32)
Exomes 𝑓: 0.24 ( 42197 hom. )

Consequence

ABCA4
NM_000350.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:19O:1

Conservation

PhyloP100: 0.299

Publications

30 publications found
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]
ABCA4 Gene-Disease associations (from GenCC):
  • ABCA4-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • cone-rod dystrophy 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • severe early-childhood-onset retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • retinitis pigmentosa 19
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 1-94010832-C-G is Benign according to our data. Variant chr1-94010832-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 99396.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.299 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.249 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA4NM_000350.3 linkc.5682G>C p.Leu1894Leu synonymous_variant Exon 40 of 50 ENST00000370225.4 NP_000341.2
ABCA4NM_001425324.1 linkc.5460G>C p.Leu1820Leu synonymous_variant Exon 39 of 49 NP_001412253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA4ENST00000370225.4 linkc.5682G>C p.Leu1894Leu synonymous_variant Exon 40 of 50 1 NM_000350.3 ENSP00000359245.3
ABCA4ENST00000465352.1 linkn.98G>C non_coding_transcript_exon_variant Exon 1 of 6 5

Frequencies

GnomAD3 genomes
AF:
0.234
AC:
35536
AN:
151902
Hom.:
4296
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.249
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.246
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.145
Gnomad FIN
AF:
0.213
Gnomad MID
AF:
0.213
Gnomad NFE
AF:
0.252
Gnomad OTH
AF:
0.217
GnomAD2 exomes
AF:
0.216
AC:
54210
AN:
251178
AF XY:
0.214
show subpopulations
Gnomad AFR exome
AF:
0.249
Gnomad AMR exome
AF:
0.179
Gnomad ASJ exome
AF:
0.239
Gnomad EAS exome
AF:
0.127
Gnomad FIN exome
AF:
0.214
Gnomad NFE exome
AF:
0.251
Gnomad OTH exome
AF:
0.229
GnomAD4 exome
AF:
0.237
AC:
346195
AN:
1461772
Hom.:
42197
Cov.:
40
AF XY:
0.234
AC XY:
170450
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.258
AC:
8623
AN:
33478
American (AMR)
AF:
0.182
AC:
8154
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.237
AC:
6190
AN:
26136
East Asian (EAS)
AF:
0.136
AC:
5382
AN:
39700
South Asian (SAS)
AF:
0.152
AC:
13096
AN:
86256
European-Finnish (FIN)
AF:
0.217
AC:
11601
AN:
53410
Middle Eastern (MID)
AF:
0.218
AC:
1255
AN:
5768
European-Non Finnish (NFE)
AF:
0.250
AC:
278409
AN:
1111916
Other (OTH)
AF:
0.223
AC:
13485
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
17339
34678
52018
69357
86696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9292
18584
27876
37168
46460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.234
AC:
35595
AN:
152020
Hom.:
4307
Cov.:
32
AF XY:
0.229
AC XY:
16984
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.250
AC:
10354
AN:
41444
American (AMR)
AF:
0.192
AC:
2935
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.246
AC:
852
AN:
3470
East Asian (EAS)
AF:
0.130
AC:
670
AN:
5142
South Asian (SAS)
AF:
0.145
AC:
702
AN:
4828
European-Finnish (FIN)
AF:
0.213
AC:
2252
AN:
10576
Middle Eastern (MID)
AF:
0.205
AC:
60
AN:
292
European-Non Finnish (NFE)
AF:
0.252
AC:
17131
AN:
67976
Other (OTH)
AF:
0.220
AC:
463
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1405
2810
4214
5619
7024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.242
Hom.:
3457
Bravo
AF:
0.233
Asia WGS
AF:
0.152
AC:
531
AN:
3478
EpiCase
AF:
0.250
EpiControl
AF:
0.250

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:19Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 10, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Jun 11, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3Other:1
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 11, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Stargardt Disease, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Age related macular degeneration 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ABCA4-related disorder Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Severe early-childhood-onset retinal dystrophy Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cone-Rod Dystrophy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinitis pigmentosa 19 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cone-rod dystrophy 3 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
2.7
DANN
Benign
0.73
PhyloP100
0.30
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801574; hg19: chr1-94476388; COSMIC: COSV64672013; COSMIC: COSV64672013; API